Download PDF
CC BY-NC-ND 4.0 · Ann Natl Acad Med Sci 2021; 57(01): 36-40
DOI: 10.1055/s-0041-1724460
Review Article

Role of Vitamin D in Risk Reduction of COVID-19: A Narrative Review

Pinki Mishra
1   Centre for Translational and Clinical Research, School of Chemical & Life Sciences, New Delhi, India
,
Rizwana Parveen
1   Centre for Translational and Clinical Research, School of Chemical & Life Sciences, New Delhi, India
,
Nidhi Bharal Agarwal 
1   Centre for Translational and Clinical Research, School of Chemical & Life Sciences, New Delhi, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

The world is in the midst of the COVID-19 pandemic. In addition to quarantine, public health interventions which can reduce the risk of infection and death are urgently required. This article discusses the roles of vitamin D in reducing the risk of COVID-19, and how vitamin D supplementation may be a useful risk reduction measure. Vitamin D can reduce the risk of infections through a variety of mechanisms: induction of cathelicidins and defensins that can lower the rate of viral replication and decrease the concentrations of pro-inflammatory cytokines, which are responsible for induction of inflammation, injuring lining of lungs and contributing to developing pneumonia. Evidence supporting the role of vitamin D in reducing the incidence of COVID-19 includes a) winter outbreak; b) a timeframe when concentrations of 25-hydroxyvitamin D (25(OH)D) are lowest; c) a small number of cases in the southern hemisphere toward the end of summer; d) a vitamin D deficiency found to lead to acute respiratory distress syndrome (ARDS); e) and a rise in case-fatality rates with increasing age and comorbid chronic diseases, both of which are associated with lower concentrations of 25(OH)D. It is recommended that people at risk of COVID-19 consider taking 10,000 IU/d of vitamin D3 for a few weeks to rapidly increase 25(OH)D concentrations, followed by 5,000 IU/d to reduce the risk of infection. Higher doses of vitamin D3 may be useful for treating people who are infected with COVID-19. To test these guidelines, randomized controlled trials and comprehensive population studies should be performed.

Keywords

COVID-19 - acute respiratory tract infection - vitamin D - 25-hydroxyvitamin D - SARS CoV-2


Publication History

Article published online:
17 February 2021

© 2021. National Academy of Medical Sciences (India). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Grant WB, Lahore H, McDonnell SL. et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 2020; 12 (04) 988
    CrossrefPubMedGoogle Scholar
  • 2 Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients 2015; 7 (06) 4240-4270
    CrossrefPubMedGoogle Scholar
  • 3 Aponte R, Cristina P. Vitamin D for Prevention of Respiratory Tract Infections. e-Library of Evidence for Nutrition Actions (eLENA). https://www.who.int/elena/titles/commentary/vitamind_pneumonia_children/en/. Accessed December 18, 2020
  • 4 Yakoob MY, Salam RA, Khan FR, Bhutta ZA. Vitamin D supplementation for preventing infections in children under five years of age. Cochrane Database Syst Rev 2016; DOI: 10.1002/14651858.CD008824.pub2.
    CrossrefPubMedGoogle Scholar
  • 5 Bergman P, Lindh ÅU, Björkhem-Bergman L, Lindh JD. Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2013; 8 (06) e65835
    CrossrefPubMedGoogle Scholar
  • 6 Charan J, Goyal JP, Saxena D, Yadav P. Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis. J Pharmacol Pharmacother 2012; 3 (04) 300-303
    CrossrefPubMedGoogle Scholar
  • 7 Martineau AR, Jolliffe DA, Hooper RL. et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017; 356: i6583
    CrossrefPubMedGoogle Scholar
  • 8 Mao S, Huang S. Vitamin D supplementation and risk of respiratory tract infections: a meta-analysis of randomized controlled trials. Scand J Infect Dis 2013; 45 (09) 696-702
    CrossrefPubMedGoogle Scholar
  • 9 Xiao L, Xing C, Yang Z. et al. Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials. Br J Nutr 2015; 114 (07) 1026-1034
    CrossrefPubMedGoogle Scholar
  • 10 Vuichard Gysin D, Dao D, Gysin CM, Lytvyn L, Loeb M. Effect of Vitamin D3 supplementation on respiratory tract infections in healthy individuals: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2016; 11 (09) e0162996
    CrossrefPubMedGoogle Scholar
  • 11 World Health Organisation. WHO Health Emergency Dashboard. WHO Coronavirus Disease (COVID-19). Available at: https://covid19.who.int/. Accessed January 21, 2020
  • 12 Ji H-L, Zhao R, Matalon S, Matthay MA. Elevated Plasmin(ogen) as a common risk factor for COVID-19 susceptibility. Physiol Rev 2020; 100 (03) 1065-1075
    CrossrefPubMedGoogle Scholar
  • 13 Shahid Z, Kalayanamitra R, McClafferty B. et al. COVID-19 and older adults: what we know. J Am Geriatr Soc 2020; 68 (05) 926-929
    CrossrefPubMedGoogle Scholar
  • 14 Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169 (04) 384-390
    CrossrefPubMedGoogle Scholar
  • 15 Jolliffe DA, Griffiths CJ, Martineau AR. Vitamin D in the prevention of acute respiratory infection: systematic review of clinical studies. J Steroid Biochem Mol Biol 2013; 136: 321-329
    CrossrefPubMedGoogle Scholar
  • 16 Bergman P, Norlin A-C, Hansen S. et al. Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open 2012; 2 (06) e001663
    CrossrefPubMedGoogle Scholar
  • 17 Laird E, Kenny RA. Vitamin D Deficiency in Ireland – Implications for COVID-19. Results from the Irish Longitudinal Study on Ageing (TILDA). Dublin, Ireland: The Irish Longitudinal Study on Ageing 2020
  • 18 Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res 2020; 32 (07) 1195-1198
    CrossrefPubMedGoogle Scholar
  • 19 Ebadi M, Montano-Loza AJ. Perspective: improving vitamin D status in the management of COVID-19. Eur J Clin Nutr 2020; 74 (06) 856-859
    CrossrefPubMedGoogle Scholar
  • 20 Kretchy IA, Asiedu-Danso M, Kretchy J-P. Medication management and adherence during the COVID-19 pandemic: perspectives and experiences from low-and middle-income countries. Res Social Adm Pharm 2021; 17 (01) 2023-2026
    CrossrefPubMedGoogle Scholar
  • 21 Vatakencherry RMJ, Saraswathy L. Association between vitamin D and hypertension in people coming for health check up to a tertiary care centre in South India. J Family Med Prim Care 2019; 8 (06) 2061-2067
    CrossrefPubMedGoogle Scholar
  • 22 Alagacone S, Verga E, Verdolini R, Saifullah SM. The association between vitamin D deficiency and the risk of resistant hypertension. Clin Exp Hypertens 2020; 42 (02) 177-180
    CrossrefPubMedGoogle Scholar
  • 23 Calvo-Romero JM, Ramiro-Lozano JM, Vitamin D. Vitamin D Levels in Patients With Type 2 Diabetes Mellitus. J Investig Med 2015; 63 (08) 921-923
    CrossrefPubMedGoogle Scholar
  • 24 Si J, Li K, Shan P, Yuan J. The combined presence of hypertension and vitamin D deficiency increased the probability of the occurrence of small vessel disease in China. BMC Neurol 2019; 19 (01) 164
    CrossrefPubMedGoogle Scholar
  • 25 Siadat ZD, Kiani K, Sadeghi M, Shariat AS, Farajzadegan Z, Kheirmand M. Association of vitamin D deficiency and coronary artery disease with cardiovascular risk factors. J Res Med Sci 2012; 17 (11) 1052-1055
    PubMedGoogle Scholar
  • 26 Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol 2008; 3 (05) 1535-1541
    CrossrefPubMedGoogle Scholar
  • 27 Muscogiuri G, Altieri B, Annweiler C. et al. Vitamin D and chronic diseases: the current state of the art. Arch Toxicol 2017; 91 (01) 97-107
    CrossrefPubMedGoogle Scholar
  • 28 Peterlik M. Vitamin D insufficiency and chronic diseases: hype and reality. Food Funct 2012; 3 (08) 784-794
    CrossrefPubMedGoogle Scholar
  • 29 Wang H, Chen W, Li D. et al. Vitamin D and chronic diseases. Aging Dis 2017; 8 (03) 346-353
    CrossrefPubMedGoogle Scholar